Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Osteoporosis/drug therapy"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bruhn, R, Pedersen, A B, Heide-Jørgensen, U & Ehrenstein, V 2023, ' Epidemiology of male osteoporosis in Denmark (1996-2018) ', Osteoporosis International, vol. 34, no. 5, pp. 935-942 . https://doi.org/10.1007/s00198-023-06720-y
UNLABELLED: Osteoporosis in men may be underdiagnosed. One in four men in Denmark will develop osteoporosis after age of 50 years, with fracture as a common presenting symptom.PURPOSE: The aim of this study was to describe epidemiology of male osteop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a01233d4d81aa6ddbb849aa326754ab
https://doi.org/10.1007/s00198-023-06720-y
https://doi.org/10.1007/s00198-023-06720-y
Publikováno v:
Aging Clinical and Experimental Research. 34(11):2625-2634
Oral bisphosphonates are a key intervention in the treatment of osteoporosis and in reducing the risk of fragility fractures. Their use is supported by over 3 decades of evidence; however, patient adherence to oral bisphosphonates remains poor in par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od________83::db29a19b859750507edbd1d5dd654385
https://doi.org/10.1007/s40520-022-02272-z
https://doi.org/10.1007/s40520-022-02272-z
Publikováno v:
Bone Reports, Vol 7, Iss C, Pp 108-113 (2017)
Background: The objectives of the physician survey component of the MUSIC OS-AP study were to describe physicians' approaches to treatment of women with postmenopausal osteoporosis and to understand the influence of gastrointestinal (GI) events on tr
Externí odkaz:
https://doaj.org/article/d00c37c1a59640daac4082a7ae3f5fdc
Autor:
Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen
Publikováno v:
BMJ (Clinical research ed.), 381:e068033. BMJ Publishing Group
Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
BMJ. BMJ Publishing Group
Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033
Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
BMJ. BMJ Publishing Group
Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033
Objective To review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterise the effect of antiosteopor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fe144b36a98726531161e01f3c5cae
https://research.vumc.nl/en/publications/fa39a0b8-bbaa-439b-be56-ad77e3290541
https://research.vumc.nl/en/publications/fa39a0b8-bbaa-439b-be56-ad77e3290541
Autor:
Nicholas Fuggle, Nasser Al-Daghri, Olivier Bock, Jaime Branco, Olivier Bruyère, Enrique Casado, Etienne Cavalier, Bernard Cortet, Maarten de Wit, Andrea Giusti, Philippe Halbout, Nicholas C. Harvey, Mickaël Hiligsmann, Jean-Marc Kaufman, Andreas Kurth, Stefania Maggi, Radmila Matijevic, Salvatore Minisola, Santiago Palacios, Régis Pierre Radermecker, Friederike Thomasius, Sansin Tuzun, Nicola Veronese, John A. Kanis, Jean-Yves Reginster, René Rizzoli, Cyrus Cooper
Publikováno v:
Fuggle, Nicholas; Al-Daghri, Nasser; Bock, Olivier; Branco, Jaime; Bruyère, Olivier; Casado, Enrique; Cavalier, Etienne; Cortet, Bernard; de Wit, Maarten; Giusti, Andrea; Halbout, Philippe; Harvey, Nicholas C; Hiligsmann, Mickaël; Kaufman, Jean-Marc; Kurth, Andreas; Maggi, Stefania; Matijevic, Radmila; Minisola, Salvatore; Palacios, Santiago; Radermecker, Régis Pierre; ... (2022). Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging clinical and experimental research, 34(11), pp. 2625-2634. Springer 10.1007/s40520-022-02272-z
Oral bisphosphonates are a key intervention in the treatment of osteoporosis and in reducing the risk of fragility fractures. Their use is supported by over 3 decades of evidence; however, patient adherence to oral bisphosphonates remains poor in par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb27608bf6b9e95b73c8c03e1b78f2ff
https://hdl.handle.net/10447/582713
https://hdl.handle.net/10447/582713
Publikováno v:
Archives of Osteoporosis, 17(1):132. Springer-Verlag London Ltd.
Summary This study is a model-based cost-effectiveness analysis of fracture liaison services (FLS) in China, suggesting that FLS could potentially lead to lifetime cost-saving in patients who have experienced a fracture. However, Chinese-specific rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9adcd0da8670470eca6dd3cbc1856d22
https://cris.maastrichtuniversity.nl/en/publications/248c6fa4-a002-4add-bc80-e2e259a7d043
https://cris.maastrichtuniversity.nl/en/publications/248c6fa4-a002-4add-bc80-e2e259a7d043
Autor:
Charlotte Beaudart, Stuart Silverman, Deborah T. Gold, Setareh A. Williams, Rich Weiss, Mickael Hiligsmann
Publikováno v:
Archives of Osteoporosis, 17(1):57. Springer-Verlag London Ltd.
Mini abstract US patients with osteoporosis included in three focus groups identified efficacy, safety, cost, and convenience as important attributes of treatment when choosing between anabolic therapies with high stated preference for the solid Micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c802c3457c0415a237aae583af34297b
https://doi.org/10.1007/s11657-022-01075-z
https://doi.org/10.1007/s11657-022-01075-z
Publikováno v:
Revue medicale suisse, vol. 18, no. 764-5, pp. 56-58
The year 2021 is marked by several articles aimed at better risk stratification of osteoporosis to define the groups of patients at very high risk of fractures or at imminent risk of fractures. This stratification determines who should benefit from a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::db5a0b4ad554cb5794af8f629626e83a
https://serval.unil.ch/notice/serval:BIB_1352CDA98BB8
https://serval.unil.ch/notice/serval:BIB_1352CDA98BB8
Autor:
Åkesson Kristina
Publikováno v:
Bulletin of the World Health Organization, Vol 81, Iss 9, Pp 657-663 (2003)
Osteoporosis has been recognized as a major public health problem for less than two decades. The increasing incidence of fragility fractures, such as vertebral, hip, and wrist fractures, first became apparent from epidemiological studies in the early
Externí odkaz:
https://doaj.org/article/c8181eb3387a4ba4a0b47cd931b64e74